JPMorgan downgrades Chamath Palihapitiya-backed Clover Health – and expects the stock to flatline over the next 16 months
Clover Health listed on the Nasdaq in January.
VIEW press/Getty Images
JPMorgan analysts have downgraded the stock of Clover Health after being underwhelmed by the healthcare company’s first-quarter earnings.
The analysts, led by Lisa Gill, cut their December…
